Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.

× No keyword cloud information.

62 in total

Review 1. Therapeutic drug monitoring of antiarrhythmic drugs.

Authors: Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

2. Dysrhythmias in acute myocardial infarction: how to treat, when to treat, and when not to treat.

Authors: J A Lopez; A Massumi
Journal: Tex Heart Inst J Date: 1992

3. A trial of prophylactic mexiletine in home coronary care.

Authors: J A Bell; J M Thomas; J R Isaacson; N J Snell; D W Holt
Journal: Br Heart J Date: 1982-09

Review 4. Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors: P Pentel; N Benowitz
Journal: Clin Pharmacokinet Date: 1984 Jul-Aug Impact factor: 6.447

5. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.

Authors: J W Upward; D Holt; P Emery; F Akhras; G Jackson
Journal: Eur J Clin Pharmacol Date: 1983 Impact factor: 2.953

Review 6. Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.

Authors: C P Denaro; N L Benowitz
Journal: Med Toxicol Adverse Drug Exp Date: 1989 Nov-Dec

7. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.

Authors: R A Allen-Narker; C J Roberts; A J Marshall; S C Jordan; D W Barritt; R M Goodfellow
Journal: Br J Clin Pharmacol Date: 1984-11 Impact factor: 4.335

8. Electrocardiographic and hemodynamic effects of tocainide (W-36095) in man.

Authors: K Swedberg; J Pehrson; L Rydén
Journal: Eur J Clin Pharmacol Date: 1978-11-09 Impact factor: 2.953

9. Rapid prediction of individual dosage requirements for lignocaine.

Authors: S Vozeh; M Berger; M Wenk; R Ritz; F Follath
Journal: Clin Pharmacokinet Date: 1984 Jul-Aug Impact factor: 6.447

Review 10. Is there a future for antiarrhythmic drug therapy?

Authors: P G Guerra; M Talajic; D Roy; M Dubuc; B Thibault; S Nattel
Journal: Drugs Date: 1998-11 Impact factor: 9.546